Related Experiment Video
Updated: Jul 9, 2026

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
Published on: November 21, 2025
Cognitive-behavioral therapy for adolescent depression: a meta-analytic investigation of changes in effect-size
Jesse B Klein1, Rachel H Jacobs, Mark A Reinecke
1Department of Psychiatry, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. jesseklein@northwestern.edu
Objective:
To explicate differences between early and recent meta-analytic estimates of the effects of cognitive-behavioral therapy (CBT) for adolescent depression.
Method:
Meta-analytic procedures were used to investigate whether methodological characteristics moderated mean effect sizes among 11 randomized, controlled trials of CBT focusing on adolescents meeting diagnostic criteria for unipolar depression.
Results:
Cumulative meta-analyses indicated that effects of CBT have decreased from large effects in early trials, and confidence intervals have become narrower. Effect sizes were significantly smaller among studies that used intent-to-treat analytic strategies, compared CBT to active treatments, were conducted in clinical settings, and featured greater methodological rigor based on CONSORT (Consolidated Standards of Reporting Trials) criteria. The mean posttreatment effect size of 0.53 was statistically significant.
Conclusions:
Differences in estimates of the efficacy of CBT for depressed adolescents may stem from methodological differences between early and more recent investigations. Overall, results support the effectiveness of CBT for the treatment of adolescent depression.
Related Concept Videos
Cognitive Therapy
Cognitive Development During Adolescence
Beck's Cognitive Therapy
Arbitrary Inference
Arbitrary inference involves making conclusions without sufficient...
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Rational Emotive Behavior Therapy
Antidepressant Drugs: MAOIs and Other Agents